Skip to main content
logo
Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
120.18
-0.17 (-0.14%)
At close: Jul 25, 2025, 4:00 PM
120.49
+0.31 (0.26%)
After-hours: Jul 25, 2025, 7:56 PM EDT

Agilent Technologies Revenue by Segment

Period EndingJan 31, 2025Oct 31, 2024Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022Jul 31, 2022Apr 30, 2022Jan 31, 2022Oct 31, 2021Jul 31, 2021Apr 30, 2021Jan 31, 2021Oct 31, 2020Jul 31, 2020Apr 30, 2020Jan 31, 2020Oct 31, 2019
Life Sciences and Applied Markets Group
3.02B3.22B3.31B3.46B3.67B3.86B4.04B4.14B
Life Sciences and Applied Markets Group Growth
-17.80%-16.62%-18.15%-16.47%-9.72%-3.77%11.16%25.37%
Agilent Crosslab Group
1.94B1.64B1.62B1.61B1.59B1.57B1.55B1.51B
Agilent Crosslab Group Growth
21.55%4.85%4.98%6.56%8.01%7.99%-5.96%-18.22%
Diagnostics and Genomics Group
1.58B1.65B1.57B1.53B1.47B1.41B1.41B1.40B
Diagnostics and Genomics Group Growth
7.33%17.18%11.39%9.53%5.89%1.44%1.96%0.87%

Revenue by End Market

Period EndingJan 31, 2025Oct 31, 2024Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022Jul 31, 2022Apr 30, 2022Jan 31, 2022Oct 31, 2021Jul 31, 2021Apr 30, 2021Jan 31, 2021Oct 31, 2020Jul 31, 2020Apr 30, 2020Jan 31, 2020Oct 31, 2019
Pharmaceutical and Biopharmaceutical
2.26B2.24B2.24B2.29B2.36B2.43B2.52B2.58B
Pharmaceutical and Biopharmaceutical Growth
-4.11%-7.85%-11.37%-11.11%-7.56%-3.26%3.83%8.93%
Chemicals and Advanced Materials
1.48B1.50B1.49B1.51B1.53B1.54B1.59B1.60B
Chemicals and Advanced Materials Growth
-3.07%-3.11%-5.99%-5.26%-1.61%1.45%9.38%14.48%
Diagnostics and Clinical
976.00M964.00M945.00M944.00M955.00M966.00M975.00M968.00M
Diagnostics and Clinical Growth
2.20%-0.21%-3.08%-2.48%-0.42%0.31%1.14%-0.41%
Environmental and Forensics
656.00M650.00M661.00M657.00M662.00M662.00M665.00M663.00M
Environmental and Forensics Growth
-0.91%-1.81%-0.60%-0.90%-0.45%0.91%4.23%5.41%
Food
603.00M592.00M596.00M603.00M625.00M628.00M643.00M643.00M
Food Growth
-3.52%-5.73%-7.31%-6.22%0.97%1.78%7.71%9.17%
Academia and Government
554.00M567.00M567.00M585.00M605.00M601.00M601.00M594.00M
Academia and Government Growth
-8.43%-5.66%-5.66%-1.52%4.13%4.34%3.80%2.77%

Revenue by Instrumentation

Period EndingJan 31, 2025Oct 31, 2024Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022Jul 31, 2022Apr 30, 2022Jan 31, 2022Oct 31, 2021Jul 31, 2021Apr 30, 2021Jan 31, 2021Oct 31, 2020Jul 31, 2020Apr 30, 2020Jan 31, 2020Oct 31, 2019
Non Instrumentation and Other
4.18B4.16B4.11B4.12B4.12B4.09B4.07B4.02B
Non Instrumentation and Other Growth
1.50%1.59%1.03%2.41%4.22%3.81%4.87%4.58%
Instrumentation
2.35B2.35B2.39B2.47B2.61B2.74B2.92B3.02B
Instrumentation Growth
-10.10%-14.15%-18.43%-18.09%-12.17%-5.68%5.26%12.57%

Revenue by Type

Period EndingJan 31, 2025Oct 31, 2024Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022Jul 31, 2022Apr 30, 2022Jan 31, 2022Oct 31, 2021Jul 31, 2021Apr 30, 2021Jan 31, 2021Oct 31, 2020Jul 31, 2020Apr 30, 2020Jan 31, 2020Oct 31, 2019
Products
4.66B4.67B4.69B4.79B4.94B5.05B5.23B5.32B
Products Growth
-5.55%-7.50%-10.43%-9.95%-5.91%-2.62%4.26%8.49%
Services and Other
1.87B1.84B1.81B1.80B1.80B1.78B1.76B1.72B
Services and Other Growth
4.00%3.14%2.78%4.64%6.83%7.28%7.38%5.97%

Revenue by Geography

Period EndingJan 31, 2025Oct 31, 2024Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022Jul 31, 2022Apr 30, 2022Jan 31, 2022Oct 31, 2021Jul 31, 2021Apr 30, 2021Jan 31, 2021Oct 31, 2020Jul 31, 2020Apr 30, 2020Jan 31, 2020Oct 31, 2019
Americas
2.61B2.57B2.60B2.64B2.68B2.73B2.75B2.75B
Americas Growth
-2.36%-5.82%-5.46%-4.11%-2.09%1.86%4.41%7.22%
APAC
2.15B2.17B2.15B2.21B2.30B2.35B2.51B2.58B
APAC Growth
-6.86%-7.67%-14.22%-14.40%-7.62%-4.86%7.45%14.38%
Europe
1.78B1.77B1.75B1.75B1.76B1.75B1.74B1.71B
Europe Growth
1.08%0.91%0.58%2.04%3.05%3.24%2.66%0.23%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.